Home > Annual Financials > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS Financial Statement Analysis
[BOM: 539730]

The Revenues of FREDUN PHARMACEUTICALS have increased by 40.03% YoY .
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 42.61 % YoY.
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539730]

ConsolidatedMar2026
Mar2025
Revenues ₹635 Cr₹454 Cr
Expenses ₹545 Cr₹401 Cr
Operating Profit (Excl OI) ₹91 Cr₹52 Cr
Other Income ₹3.66 Cr₹2.45 Cr
Interest ₹39 Cr₹22 Cr
Depreciation ₹8.25 Cr₹5.04 Cr
Profit Before Tax ₹47 Cr₹27 Cr
Profit After Tax ₹33 Cr₹20 Cr
Consolidated Net Profit ₹33 Cr₹20 Cr
Earnings Per Share (Rs)₹59.61₹41.80
PAT Margin (%)5.134.35
ROE(%)16.0913.96
ROCE(%)21.3416.16
Total Debt/Equity(x)0.841.18

Key Financials

Market Cap : ₹ 1,435.6 Cr
Revenue (TTM) : ₹ 639.1 Cr
Net Profit(TTM) : ₹ 37.5 Cr
EPS (TTM) : ₹ 68.1
P/E (TTM) : 38.3

Industry Peers & Returns1W1M1Y
FREDUN PHARMACEUTICALS 16% 13.4% 242.1%
SUN PHARMACEUTICAL INDUSTRIES 1.4% -4.5% 6.5%
DIVIS LABORATORIES 0.1% -2.5% -0.1%
TORRENT PHARMACEUTICALS -2.7% 1.2% 39.3%
CIPLA -2.3% -5.3% -9.8%
DR REDDYS LABORATORIES -0.5% -4.7% -5.4%
MANKIND PHARMA -0.3% -5.3% -0.9%
LUPIN -0.3% 0.6% 12.3%
ZYDUS LIFESCIENCES -4% 7.1% 10.2%


FREDUN PHARMACEUTICALS Revenues
[BOM: 539730]

Y-o-Y

40.03 %

5 Yr CAGR

40.03 %

Years Revenues % Change
Mar2026 ₹635 Cr
40.03
Mar2025 ₹454 Cr -


FREDUN PHARMACEUTICALS Operating Profit
[BOM: 539730]

Y-o-Y

73.29 %

5 Yr CAGR

73.29 %

Years Operating Profit % Change
Mar2026 ₹91 Cr
73.29
Mar2025 ₹52 Cr -

Operating Margins
Y-o-Y

23.79 %

5 Yr CAGR

23.79 %

Years Operating Margin% % Change
Mar2026 14.31%
23.79
Mar2025 11.56% -

FREDUN PHARMACEUTICALS Profit After Tax
[BOM: 539730]

Y-o-Y

65.28 %

5 Yr CAGR

65.28 %

Years Profit After Tax % Change
Mar2026 ₹33 Cr
65.28
Mar2025 ₹20 Cr -

PAT Margins
Y-o-Y

17.93 %

5 Yr CAGR

17.93 %

Years PAT Margin(%) % Change
Mar2026 5.13 %
17.93
Mar2025 4.35 % -

FREDUN PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539730]

Y-o-Y

42.61 %

5 Yr CAGR

42.61 %

Years EPS % Change
Mar2026 ₹60
42.61
Mar2025 ₹42 -

FREDUN PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539730]

Y-o-Y

32.05 %

5 Yr CAGR

32.05 %

Years ROCE % Change
Mar2026 21.34%
32.05
Mar2025 16.16% -

FREDUN PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹2,610.2
Current MarketCap: ₹ 1,435.6 Cr
Updated EOD on :Jun 17,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

16%

13.4%

242.1%

SENSEX

4.3%

2.6%

-6.4%

FREDUN PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about FREDUN PHARMACEUTICALS Financials


How the annual revenues of FREDUN PHARMACEUTICALS have changed ?

The Revenues of FREDUN PHARMACEUTICALS have increased by 40.03% YoY .

How the Earnings per Share (EPS) of FREDUN PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 42.61 % YoY .